ConductScience.org, home

Paper4279136

A review of chemotherapy in gastric cancer.

Comis RL and 1 other. Cancer, 1974. Cited by 98 papers, by iCite.

Cite this record

ConductScience Library. A review of chemotherapy in gastric cancer. Papers, record 4279136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4279136

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A review of chemotherapy in gastric cancer.
PubMed
Journal
Cancer
PubMed
Year
1974
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
98
iCite
Relative citation ratio, by iCite
4
iCite
Revised in PubMed
2022-04-08
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Comis RLR L
2Carter SKS K

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Stomach NeoplasmsMajor topic
Adenocarcinoma
Carmustine
Chlorambucil
Chromomycins
Cyclophosphamide
Cytarabine
Drug Evaluation
Drug Therapy, Combination
Floxuridine
Fluorouracil
Humans
Mechlorethamine
Methotrexate
Mitomycins
Nitrosourea Compounds
Olivomycins

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT01671449S-1 and Cisplatin (3 Weekly) Versus S-1 and Oxaliplatin Combination Chemotherapy for Advanced Gastric CancerBackground

Source ClinicalTrials.gov

Download CSV of trials

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 98 citations.

PMIDTitleJournalYearIn PapersSource
31205469LncRNA PVT1 Mediates Antiapoptosis and 5-Fluorouracil Resistance via Increasing Bcl2 Expression in Gastric Cancer.J Oncol2019https://conductscience.org/library/papers/31205469PubMed
27724887Phase II study of TP300 in patients with advanced gastric or gastro-oesophageal junction adenocarcinoma.BMC Cancer2016https://conductscience.org/library/papers/27724887PubMed
26137913Regression of Gastric Cancer by Systemic Injection of RNA Nanoparticles Carrying both Ligand and siRNA.Sci Rep2015https://conductscience.org/library/papers/26137913PubMed
23761814High efficacy of combination chemotherapy with S-1 and low-dose docetaxel for the treatment of highly advanced gastric cancer with peritoneal dissemination: A case report.Oncol Lett2013https://conductscience.org/library/papers/23761814PubMed
21283405Malignancy in the aged: two 'cures' of stomach cancer.Can Fam Physician1983https://conductscience.org/library/papers/21283405PubMed
20396554Randomized phase III trial of cisplatin, epirubicin, leucovorin, 5-fluorouracil (PELF) combination versus 5-fluorouracil alone as adjuvant chemotherapy in curative resected stage III gastric cancer.Cancer Res Treat2004https://conductscience.org/library/papers/20396554PubMed
19956484Chemotherapy for advanced gastric cancer: slow but further progress.Cancer Res Treat2005https://conductscience.org/library/papers/19956484PubMed
18756042Phase II study of paclitaxel, cisplatin, and 5-fluorouracil combination chemotherapy in patients with advanced gastric cancer.J Korean Med Sci2008https://conductscience.org/library/papers/18756042PubMed
17949350Enzymatic activities of uridine and thymidine phosphorylase in normal and cancerous uterine cervical tissues.Hum Cell2007https://conductscience.org/library/papers/17949350PubMed
12966415Irinotecan is active in chemonaive patients with metastatic gastric cancer: a phase II multicentric trial.Br J Cancer2003https://conductscience.org/library/papers/12966415PubMed
11291830A phase I study of vitamin E, 5-fluorouracil and leucovorin for advanced malignancies.Invest New Drugs2001https://conductscience.org/library/papers/11291830PubMed
9013471
Phase II trial of docetaxel (Taxotere) in patients with adenocarcinoma of the upper gastrointestinal tract previously untreated with cytotoxic chemotherapy: the Eastern Cooperative Oncology Group (ECOG) results of protocol E1293.
Med Oncol1996https://conductscience.org/library/papers/9013471PubMed
6793759Late results of postoperative long term cancer chemotherapy for advanced carcinoma of the stomach.Jpn J Surg1981https://conductscience.org/library/papers/6793759PubMed
6668775Combination chemotherapy enhances survival of patients with unresectable gastric cancer.Jpn J Surg1983https://conductscience.org/library/papers/6668775PubMed
6406513
Chemotherapeutic study on Yoshida sarcoma ascites cells implanted into the glandular stomach of rats. Monotherapy with 5-fluorouracil, methyl-CCNU, mitomycin C, adriamycin, and cytosine arabinoside, and combination therapy with respective two-drug combinations.
J Cancer Res Clin Oncol1983https://conductscience.org/library/papers/6406513PubMed
6349141An interim report of a prospective, randomized, controlled study of adjuvant chemotherapy in operable gastric cancer: British Stomach Cancer Group.World J Surg1983https://conductscience.org/library/papers/6349141PubMed
6165425Chemotherapy following palliative resection of gastric cancer.Br J Surg1981https://conductscience.org/library/papers/6165425PubMed
3902267The effects of multiple combination chemotherapy with vincristine, cyclophosphamide (Endoxan), methotrexate, 5-fluorouracil, adriamycin and prednisolone (VEMFAH) for advanced breast cancer.Cancer Chemother Pharmacol1985https://conductscience.org/library/papers/3902267PubMed
1960901The effectiveness of a combination of etoposide/adriamycin/cisplatin (EAP) against inoperable gastric cancer--report of a histologically proven case.Jpn J Surg1991https://conductscience.org/library/papers/1960901PubMed
387542Chemotherapy in advanced gastric cancer: a controlled, prospective, randomised multi-centre study.Gut1979https://conductscience.org/library/papers/387542PubMed

See all 21 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4279136

GET https://conductscience.org/api/papers/v1/4279136/cited_by?page=2